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Abstract
The serotonin1A receptor is an important member of the G-protein coupled receptor family, and is involved in a variety of cognitive,
behavioral, and developmental functions. None of the subtypes of G-protein coupled serotonin receptors have yet been purified
to homogeneity from natural sources. We report here, for the first time, the solubilization of human serotonin1A receptors stably
expressed in neuronal (HN2) cells. Importantly, ligand binding assay shows that the serotonin1A receptor solubilized this way is
functionally active. The effective solubilization of the serotonin1A receptor from neuronal cells represents an important step toward
the purification of the receptor in native-like membrane environment.
© 2007 Elsevier Ireland Ltd. All rights reserved.
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1. Introduction
The G-protein coupled receptors (GPCRs) are the
largest class of molecules involved in signal transduction
across membranes (Pierce et al., 2002), and represent
a major fraction of membrane proteins. GPCRs are
prototypical members of the family of seven trans-
membrane domain proteins and constitute ∼2% of the
human genome (Fredriksson et al., 2003). They respond
to a diverse variety of ligands and mediate multiple
physiological processes and have therefore emerged as
Abbreviations: 5-HT1A receptor, 5-hydroxytryptamine-1A
receptor; 8-OH-DPAT, 8-hydroxy-2(di-N-propylamino)tetralin; BCA,
bicinchoninic acid; CHAPS, 3-[(3-cholamidopropyl)-dimethylammo-
nio]-1-propanesulfonate; GPCR, G-protein coupled receptor; PEG,
polyethylene glycol; PMSF, phenylmethylsulfonyl fluoride
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major targets for the development of novel drug can-
didates in all clinical areas (Insel et al., 2007). The
serotonin1A (also referred to as 5-HT1A) receptor is
an important neurotransmitter receptor and is a repre-
sentative member of the large family of GPCRs. It is
the most extensively studied of the serotonin receptors
for a number of reasons. The serotonin1A receptor is
involved in the generation and modulation of a variety
of cognitive, behavioral, and developmental functions
(for a recent review, see Pucadyil et al., 2005). The
serotonin1A receptor agonists and antagonists represent
major classes of molecules with potential therapeutic
effects in anxiety- or stress-related disorders. Interest-
ingly, mice lacking the serotonin1A receptor exhibit
enhanced anxiety-related behavior (Julius, 1998) and
represent an important animal model for genetic vul-
nerability to conditions such as anxiety disorders and
aggression (Toth, 2003).
Membrane protein purification represents an area of
considerable challenge in contemporary membrane biol-
ed.
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gy. Studies carried out on purified and reconstituted
embrane receptors have considerably advanced our
nowledge of the molecular aspects of receptor func-
ion (Gether, 2000). In this context, it is noteworthy that
one of the subtypes of G-protein coupled serotonin
eceptors have yet been purified to homogeneity from
atural sources. An essential criterion for purification of
n integral membrane protein is that the protein must be
arefully removed from the native membrane and indi-
idually dispersed in solution. This process is known
s solubilization and is most effectively accomplished
sing amphiphilic detergents (Garavito and Ferguson-
iller, 2001; Kalipatnapu and Chattopadhyay, 2005).
olubilization of a membrane protein is a process in
hich the proteins and lipids that are held together
n the native membrane are suitably dissociated in a
uffered detergent solution. The controlled dissociation
f the membrane results in the formation of small clus-
ers of lipid and protein that remain dissolved in the
queous solution. Effective solubilization and purifica-
ion of G-protein coupled receptors in a functionally
ctive form represent important steps in understand-
ng structure–function relationship and pharmacological
haracterization of a specific receptor. Yet, solubilization
f a membrane protein with retention of activity poses a
ormidable challenge since many detergents irreversibly
enature membrane proteins (Garavito and Ferguson-
iller, 2001). This is the main reason for the rather
odest list of membrane proteins which have been sol-
bilized with retention of function.
Mammalian cells in culture heterologously express-
ng membrane receptors represent convenient systems
o address problems in receptor biology due to
igher expression levels of the receptors (Tate and
risshammer, 1996). An important consideration in such
xpression systems is selecting a cell type which is
erived from the tissue of natural occurrence of the
eceptor. This is particularly true for receptors of neu-
al origin since the membrane lipid composition of cells
n the nervous system is unique and displays remarkable
iversity (Sastry, 1985). Lipids found in neuronal mem-
ranes are often necessary for maintaining the structure
nd function of neuronal receptors. Keeping this in mind,
e earlier reported the pharmacological and functional
haracterization of the human serotonin1A receptor sta-
ly expressed in HN2 cells (Paila and Chattopadhyay,
006), which are a hybrid cell line between hippocampal
ells and mouse neuroblastoma. Our results showed that
he human serotonin1A receptor expressed in HN2 cells
isplays characteristic features found in the native recep-
or isolated from bovine hippocampus and represents a
ealistic model system for the receptor. In this paper, wed Physics of Lipids 150 (2007) 244–249 245
report the solubilization of serotonin1A receptors stably
expressed in HN2 cells using the zwitterionic detergent
CHAPS. More importantly, we show by ligand binding
assay that the serotonin1A receptor solubilized this way
is functionally active. This constitutes the first report
describing the solubilization of functional serotonin1A
receptors expressed in neuronal cells.
2. Materials and methods
2.1. Materials
CHAPS, EDTA, MgCl2, MnCl2, NaCl, PMSF, Tris,
PEG, polyethylenimine, fetal calf serum, penicillin,
streptomycin, gentamycin sulphate, sodium bicarbon-
ate and serotonin were obtained from Sigma Chemical
Co. (St. Louis, MO). DMEM (Dulbecco’s Modified
Eagle Medium) and geneticin (G-418) were from Life
Technologies (Grand Island, NY). [3H]8-OH-DPAT
(specific activity 106.0 Ci/mmol) was purchased from
DuPont New England Nuclear (Boston, MA). GF/B
glass microfiber filters were from Whatman International
(Kent, UK). BCA reagent for protein estimation was
obtained from Pierce (Rockford, IL). All other chem-
icals used were of the highest purity available. Water
was purified through a Millipore (Bedford, MA) Milli-Q
system and used throughout.
2.2. Methods
2.2.1. Cells and cell culture
The intronless human genomic clone G-21 (Fargin et
al., 1988) which encodes the human serotonin1A recep-
tor was used to generate stable transfectants in HN2
cells which are a hybrid cell line between hippocam-
pal cells and mouse neuroblastoma (Lee et al., 1990).
These cells expressing the human serotonin1A receptor,
originally referred to as HN2-5 (Banerjee et al., 1993),
were a generous gift from Dr. Probal Banerjee (Col-
lege of Staten Island, City University of New York).
These cells are referred to as HN2-5-HT1AR (Paila and
Chattopadhyay, 2006). Cells were grown in DMEM sup-
plemented with 3.7 g/l of sodium bicarbonate, 10% fetal
calf serum, 60g/ml penicillin, 50g/ml streptomycin,
50g/ml gentamycin sulfate, and 200g/ml geneticin
in a humidified atmosphere with 5% CO2 at 37 ◦C.
2.2.2. Preparation of cell membranes
Cell membranes were prepared as described earlier
(Paila and Chattopadhyay, 2006). Confluent cells were
harvested by treatment with ice-cold buffer containing
10 mM Tris, 5 mM EDTA, 0.1 mM PMSF, pH 7.4. Cells
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Fig. 1. Effect of NaCl concentration on the solubilization efficiency
of the human serotonin1A receptor stably expressed in HN2 cells. Val-
ues are expressed as percentages of specific binding of the agonist
[3H]8-OH-DPAT obtained for control membranes without solubiliza-
tion. The concentration of CHAPS used was 5 mM and the total protein
concentration was 2 mg/ml in all cases. Specific binding is normalized
in a Packard Tri-Carb 1500 scintillation counter using
5 ml of scintillation fluid. The specific [3H]8-OH-DPAT
binding shown in Figs. 1 and 2 are normalized to the
amount of total protein used in the assay.
Fig. 2. Effect of total protein concentration on the solubilization effi-
ciency of the human serotonin1A receptor stably expressed in HN2
cells. Values are expressed as percentages of specific binding of the
agonist [3H]8-OH-DPAT obtained for control membranes without sol-246 Md. Jafurulla, A. Chattopadhyay / Chem
were then homogenized at 4 ◦C at maximum speed with a
Polytron homogenizer. The cell lysate was centrifuged at
500 × g for 10 min at 4 ◦C and the resulting postnuclear
supernatant was centrifuged at 40,000 × g for 30 min at
4 ◦C. The pellet thus obtained was suspended in 50 mM
Tris buffer, pH 7.4, flash frozen in liquid nitrogen and
stored at −70 ◦C till further use. Total protein concen-
tration in isolated membranes was determined using the
BCA assay (Smith et al., 1985).
2.2.3. Solubilization of cell membranes
Cell membranes were treated with 5 mM CHAPS and
varying concentrations of NaCl or protein, in buffer con-
taining 50 mM Tris, 1 mM EDTA, 10 mM MgCl2, pH 7.4
for 30 min at 4 ◦C with occasional shaking. Membranes
were briefly sonicated (5 s) using a Branson model 250
sonifier fitted with a microtip and mildly homogenized
using a hand-held Dounce homogenizer (five times) at
the beginning of the incubation. The homogenization
was repeated at the end of the incubation period. After
incubation for 30 min, the contents were centrifuged at
100,000 × g for 1 h at 4 ◦C. The clear supernatant was
subjected to PEG precipitation. PEG precipitation of the
CHAPS solubilized cell membranes was performed to
remove NaCl from the solubilized extract since the ago-
nist binding of the serotonin1A receptor was found to
be inhibited by NaCl (Harikumar and Chattopadhyay,
1998). PEG precipitation was carried out by diluting
the solubilized extract with equal volume of 40% (w/w)
PEG-8000 prepared in buffer containing 50 mM Tris,
1 mM EDTA, 10 mM MgCl2, pH 7.4. Following vigor-
ous vortexing and incubation on ice for 10 min, samples
were centrifuged at 15,000 × g for 10 min at 4 ◦C. The
pellet was carefully rinsed with 50 mM Tris, pH 7.4
buffer and resuspended in the same buffer and used for
radioligand binding assays immediately.
2.2.4. Agonist binding assays
Agonist binding assays of cell membranes and
PEG-precipitated CHAPS solubilized cell membranes
were performed as described earlier (Paila and
Chattopadhyay, 2006). Briefly, tubes in duplicate con-
taining membranes were incubated in a total volume
of 1 ml of buffer containing 50 mM Tris, 1 mM EDTA,
10 mM MgCl2, 5 mM MnCl2, pH 7.4 in the presence of
0.29 nM [3H]8-OH-DPAT for 1 h at 25 ◦C. Non-specific
binding was determined by performing the assay in the
presence of 10M unlabeled serotonin. The incuba-
tion was terminated by rapid filtration under vacuum
in a Brandel cell harvester (Gaithersburg, MD) through
Whatman GF/B 2.5 cm diameter glass microfiber filters
(1.0m pore size), which were presoaked in 0.15% (w/v)to the amount of total protein used in the assay. The data points are
means ± S.E. from at least three independent experiments. See Section
2 for other details.
polyethylenimine for 1 h (Bruns et al., 1983). The filters
were then washed three times with 3 ml each of ice-cold
water, dried, and the retained radioactivity was measuredubilization. The concentration of CHAPS used was 5 mM and NaCl
concentration was 1 M in all cases. Specific binding is normalized
to the amount of total protein used in the assay. The data points are
means ± S.E. from four independent experiments. See Section 2 for
other details.
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. Results
The choice of a suitable detergent is an important con-
ideration in the process of solubilization (Kalipatnapu
nd Chattopadhyay, 2005). The mild, non-denaturing,
witterionic detergent CHAPS was previously found
o be the most efficient detergent in functional solubi-
ization of the serotonin1A receptor upon comparison
f the solubilizing efficiencies of 14 different deter-
ents (Banerjee et al., 1995). CHAPS is a derivative
f the naturally occurring bile salts and combines use-
ul features of both the bile salt hydrophobic group and
he N-alkyl sulfobetaine-type polar group (Hjelmeland,
980). CHAPS has been shown to be an efficient deter-
ent for solubilization since it is effective in breaking
rotein–protein interactions. Interestingly, we have pre-
iously shown that the critical micelle concentration
CMC) of CHAPS is dependent on the salt concentra-
ion of the medium and there is significant reduction in
MC with increasing salt concentration. For example,
he CMC of CHAPS decreases from 6.41 mM in absence
f any salt to 4.34 mM in presence of 1 M NaCl which
mounts to a reduction of ∼32% (Chattopadhyay and
arikumar, 1996). PEG precipitation of the CHAPS-
olubilized membrane was performed to remove NaCl
rom the solubilized extract since the agonist binding of
he serotonin1A receptor is inhibited by NaCl (Harikumar
nd Chattopadhyay, 1998). This procedure constitutes
method in which the detergent along with salt is
apidly removed (Ofri et al., 1992) thereby overcom-
ng the problem of long dialysis periods (Medrano et al.,
989). We have previously shown that 5 mM CHAPS is
uitable for optimal solubilization of the hippocampal
erotonin1A receptor. Higher concentration of CHAPS
esulted in relatively inefficient solubilization, irrespec-
ive of NaCl concentration (Chattopadhyay et al., 2002).
he solubilization efficiency of serotonin1A receptors
rom HN2-5-HT1AR cell membranes, as monitored by
he specific binding of the agonist [3H]8-OH-DPAT as a
unction of NaCl concentration is shown in Fig. 1. Solu-
ilization efficiencies were calculated as percentages of
pecific [3H]8-OH-DPAT binding in solubilized mem-
ranes, normalized to specific [3H]8-OH-DPAT binding
n control membranes in the absence of solubilization
i.e., without CHAPS treatment). Fig. 1 shows that the
olubilization efficiency is marginal up to 0.5 M NaCl.
he extent of solubilization shows a sharp increase when
aCl concentration is increased to 1 M. The solubiliza-ion efficiency appears to decrease considerably when
aCl concentration was increased to 1.5 M. Optimal sol-
bilization is therefore achieved using 5 mM CHAPS in
resence of 1 M NaCl. The concept of micelle formationd Physics of Lipids 150 (2007) 244–249 247
is relevant to solubilization and reconstitution studies of
membrane proteins since it appears that there is some
correlation between the ability to form micelles and
the concentration of detergent required for solubiliza-
tion (Rivnay and Metzger, 1982). As mentioned above,
although this concentration of CHAPS is lower than lit-
erature CMC of CHAPS, we have previously shown that
CHAPS exists in micellar form at this concentration
(5 mM) in presence of 1 M NaCl (Chattopadhyay and
Harikumar, 1996).
The process of solubilization involves multiple
changes in organization of the membrane and is depen-
dent on a host of membrane parameters (Kalipatnapu
and Chattopadhyay, 2005). The ratio of detergent to pro-
tein used during solubilization represents a crucial factor
for optimal solubilization. The solubilization efficiency
of the serotonin1A receptor in HN2-5-HT1AR cell mem-
branes was found to depend on the total concentration
of the protein in the membrane when the concentration
of CHAPS was kept constant. Fig. 2 shows that chang-
ing the protein concentration (while keeping the CHAPS
and NaCl concentrations fixed at 5 mM and 1 M, respec-
tively) alters the solubilization of HN2-5-HT1AR cell
membranes. Solubilization was carried out with total
protein concentration in the range of 1– 4 mg/ml. Fig. 2
shows that solubilization efficiency is moderate when
the protein concentration of 1 mg/ml is used with a sharp
increase when the concentration is increased to 2 mg/ml.
With further increase in protein concentration to 3 and
4 mg/ml, the solubilization efficiency is found to reduce.
Under this condition, a total protein concentration of
2 mg/ml was therefore found to be optimal. These results
show that careful control of salt and protein concentra-
tion is crucial for optimal solubilization of membrane
receptors expressed in neuronal cells in culture.
4. Discussion
It is estimated that up to 50% of clinically prescribed
drugs act as either agonists or antagonists at GPCRs
which points out their immense therapeutic potential
(Karnik et al., 2003). A useful approach for performing
pharmacological studies on GPCRs is to use a functional
receptor system that converts receptor–ligand interaction
into a cellular signal which allows to monitor the rela-
tionship between concentration and response (Kenakin,
1997). With the advent of molecular biology, there
have been an increasing number of genetically engi-
neered recombinant receptor systems for the study of
drug–receptor interactions. This has led to a correspond-
ing increase in the testing of new drugs in recombinant
receptor systems. However, differences in host mem-
istry an248 Md. Jafurulla, A. Chattopadhyay / Chem
brane lipid composition often complicate interpretation
of drug testing results in such systems, and can lead
to receptors with characteristics different from native
receptors. For example, it has earlier been reported that
although the rat cortical serotonin1A receptor exists only
in the high affinity state in its native environment, it
displays both high and low affinity when expressed
in HEK293 cells (Watson et al., 2000). It is therefore
judicious to work with cellular systems in which the
membrane lipid composition closely mimics the native
lipid environment. Our choice of HN2 cells for solubi-
lizing serotonin1A receptors is based on the observation
that cell lines of neural origin represent realistic models
for understanding signal transduction in neuronal cells
(Lee et al., 1990).
Since native tissues (of neuronal origin in particu-
lar) often have very low quantities of a specific type
of receptor, solubilization and purification of neuronal
receptors from native sources continue to be challeng-
ing issues in contemporary membrane biology. It is in
this context that membrane receptors solubilized from
a cell line with native-like membrane lipid environment
gains significance. In the present study, we have stan-
dardized conditions for the optimum solubilization of
active serotonin1A receptors from HN2-5-HT1AR cell
membranes. We could achieve optimum solubilization
using 5 mM CHAPS in presence of 1M NaCl and with
a total protein concentration of 2 mg/ml. The effective
solubilization of the serotonin1A receptor from neu-
ronal cells reported here represents a crucial step toward
the purification of the receptor in native-like membrane
environment. Effective solubilization and purification
of membrane receptors with optimum ligand binding
activity and intact signal transduction components repre-
sent important steps in understanding structure–function
relationship and pharmacological characterization of a
specific receptor, and may constitute the first step in the
detailed molecular characterization of GPCRs.
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